is tirzepatide coming off the market No, FDA not taking GLP-1 medications the — but the compounded “copycat” versions may be getting a lot harder to access. This is where patient safety, cost, and access all collide., Tirzepatide Statistics 2026: Mounjaro &

Website External link for FuturHealth Industry Wellness and Fitness Services Company size 51-200 employees Type Privately Held Employees at FuturHealth Updates FuturHealth is among the first platforms to offer Eli Lilly's oral GLP-1 receptor agonist, Foundayo (orforglipron) This is a meaningful moment for access

Understanding contraindications and risk factors helps ensure safe, personalized therapy decisions

If you stop these medications, especially if you stop them suddenly, its possible to regain some weight, especially if you havent made sustainable diet and exercise changes

Weve secured over $4 billion in compensation for people harmed at no fault of their own

The long-term reduction in treated follicles means many patients see less regrowth, finer hair, and less need for daily maintenance

A Team of Experts We are guided by qualified doctors and specialists to ensure your safety and well-being at every step